SNSE
Income statement / Annual
Last year (2024), Sensei Biotherapeutics, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Sensei Biotherapeutics, Inc.'s net income was -$30.16 M.
See Sensei Biotherapeutics, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$551.00 K
|
$571.00 K
|
$1.81 M
|
$685.00 K
|
$209.00 K
|
$73.00 K
|
$44.00 K
|
| Gross Profit |
-$551.00 K
|
-$571.00 K
|
-$1.81 M
|
-$685.00 K
|
-$209.00 K
|
-$73.00 K
|
-$44.00 K
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$18.63 M
|
$18.30 M
|
$29.58 M
|
$21.66 M
|
$11.92 M
|
$8.35 M
|
$8.23 M
|
| General & Administrative Expenses |
$0.00
|
$18.67 M
|
$0.00
|
$0.00
|
$7.53 M
|
$0.00
|
$4.51 M
|
| Selling & Marketing Expenses |
$0.00
|
$100.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$12.49 M
|
$18.77 M
|
$17.73 M
|
$15.14 M
|
$7.53 M
|
$4.01 M
|
$4.51 M
|
| Other Expenses |
$0.00
|
-$571.00 K
|
$0.00
|
$0.00
|
-$209.00 K
|
$0.00
|
$28.00 K
|
| Operating Expenses |
$31.11 M
|
$36.49 M
|
$47.31 M
|
$36.80 M
|
$19.24 M
|
$12.36 M
|
$12.74 M
|
| Cost And Expenses |
$31.66 M
|
$37.06 M
|
$49.12 M
|
$37.48 M
|
$19.45 M
|
$12.44 M
|
$12.74 M
|
| Interest Income |
$2.55 M
|
$3.62 M
|
$1.78 M
|
$800.00 K
|
$1.69 K
|
$2.26 K
|
$0.00
|
| Interest Expense |
$90.00 K
|
$144.00 K
|
$219.00 K
|
$670.00 K
|
$1.69 M
|
$2.26 M
|
$327.00 K
|
| Depreciation & Amortization |
$551.00 K
|
$3.68 M
|
$1.81 M
|
$685.00 K
|
$209.00 K
|
$73.00 K
|
$44.00 K
|
| EBITDA |
-$29.52 M |
-$33.39 M |
-$46.56 M |
-$35.44 M |
-$18.20 M |
-$14.41 M |
-$12.70 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$1.51 M
|
$2.96 M
|
$532.00 K
|
$688.00 K
|
-$649.00 K
|
-$4.30 M
|
-$299.00 K
|
| Income Before Tax |
-$30.16 M
|
-$34.10 M
|
-$48.59 M
|
-$36.79 M
|
-$20.10 M
|
-$16.74 M
|
-$13.04 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$30.16 M
|
-$34.10 M
|
-$48.59 M
|
-$36.79 M
|
-$20.10 M
|
-$16.74 M
|
-$13.04 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-1.2 |
-1.22 |
-1.58 |
-1.33 |
-0.67 |
-0.65 |
-19.03 |
| EPS Diluted |
-1.2 |
-1.22 |
-1.58 |
-1.33 |
-0.67 |
-0.65 |
-19.03 |
| Weighted Average Shares Out |
$25.12 M
|
$27.95 M
|
$30.70 M
|
$27.71 M
|
$30.59 M
|
$29.33 M
|
$685.16 K
|
| Weighted Average Shares Out Diluted |
$25.12 M
|
$27.95 M
|
$30.70 M
|
$27.71 M
|
$30.59 M
|
$29.33 M
|
$685.16 K
|
| Link |
|
|
|
|
|
|
|
